Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment
NCT: NCT04583215 · ACTIVE_NOT_RECRUITING
Brief Summary
More than 5 million people live with Alzheimer's dementia (AD) in North America. No effective treatment exists yet probably because by the time AD has developed it is too late to intervene. Mild Cognitive Impairment (MCI) is a clinical state that typically precedes AD. In MCI, the prefrontal cortex supports compensatory mechanisms that depend on robust synaptic plasticity and that delay progression to AD. Using a neurostimulation approach that enhances prefrontal cortical plasticity in vivo, this project aims to enhance prefrontal cortical plasticity and function in patients with MCI. If successful, this project would discover a treatment modality that enhances compensation in MCI and ultimately, prevents progression to AD.
Frequently Asked Questions
What is Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment?
Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment is a clinical trial registered under NCT04583215. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04583215?
The current status of NCT04583215 (Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment) is: ACTIVE_NOT_RECRUITING.
When did Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment start?
Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment started on 2020-10-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.